571 related articles for article (PubMed ID: 18579287)
1. The role of CXC chemokines and their receptors in cancer.
Vandercappellen J; Van Damme J; Struyf S
Cancer Lett; 2008 Aug; 267(2):226-44. PubMed ID: 18579287
[TBL] [Abstract][Full Text] [Related]
2. Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response.
Koizumi K; Hojo S; Akashi T; Yasumoto K; Saiki I
Cancer Sci; 2007 Nov; 98(11):1652-8. PubMed ID: 17894551
[TBL] [Abstract][Full Text] [Related]
3. Distinct CXC chemokines mediate tumorigenicity of prostate cancer cells.
Moore BB; Arenberg DA; Stoy K; Morgan T; Addison CL; Morris SB; Glass M; Wilke C; Xue YY; Sitterding S; Kunkel SL; Burdick MD; Strieter RM
Am J Pathol; 1999 May; 154(5):1503-12. PubMed ID: 10329603
[TBL] [Abstract][Full Text] [Related]
4. The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management.
Ullah A; Jiao W; Shen B
Cell Mol Biol Lett; 2024 May; 29(1):73. PubMed ID: 38745115
[TBL] [Abstract][Full Text] [Related]
5. Sulfotyrosine recognition as marker for druggable sites in the extracellular space.
Ziarek JJ; Heroux MS; Veldkamp CT; Peterson FC; Volkman BF
Int J Mol Sci; 2011; 12(6):3740-56. PubMed ID: 21747703
[TBL] [Abstract][Full Text] [Related]
6. Pro-inflammatory cytokines and CXC chemokines as game-changer in age-associated prostate cancer and ovarian cancer: Insights from preclinical and clinical studies' outcomes.
Ullah A; Chen Y; Singla RK; Cao D; Shen B
Pharmacol Res; 2024 Jun; 204():107213. PubMed ID: 38750677
[TBL] [Abstract][Full Text] [Related]
7. The Role of CXCL11 and its Receptors in Cancer: Prospective but Challenging Clinical Targets.
Wang J; Ouyang X; Zhu W; Yi Q; Zhong J
Cancer Control; 2024; 31():10732748241241162. PubMed ID: 38533911
[TBL] [Abstract][Full Text] [Related]
8. Chemokines and Their Receptors: Predictors of Therapeutic Potential in Tumor Microenvironment on Esophageal Cancer.
Huang CG; Liu Q; Zheng ST; Liu T; Tan YY; Peng TY; Chen J; Lu XM
Dig Dis Sci; 2024 May; 69(5):1562-1570. PubMed ID: 38580886
[TBL] [Abstract][Full Text] [Related]
9. CXCL3: A key player in tumor microenvironment and inflammatory diseases.
Bao Y; Tong C; Xiong X
Life Sci; 2024 Jul; 348():122691. PubMed ID: 38714265
[TBL] [Abstract][Full Text] [Related]
10. CXCL12-3' A polymorphism and lung cancer metastases protection: new perspectives in immunotherapy?
Coelho A; Calçada C; Catarino R; Pinto D; Fonseca G; Medeiros R
Cancer Immunol Immunother; 2006 Jun; 55(6):639-43. PubMed ID: 16155757
[No Abstract] [Full Text] [Related]
11. The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancer.
Vandercappellen J; Van Damme J; Struyf S
Cytokine Growth Factor Rev; 2011 Feb; 22(1):1-18. PubMed ID: 21111666
[TBL] [Abstract][Full Text] [Related]
12. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
[TBL] [Abstract][Full Text] [Related]
13. CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression.
Sun X; Cheng G; Hao M; Zheng J; Zhou X; Zhang J; Taichman RS; Pienta KJ; Wang J
Cancer Metastasis Rev; 2010 Dec; 29(4):709-22. PubMed ID: 20839032
[TBL] [Abstract][Full Text] [Related]
14. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
Cabrero-de Las Heras S; Martínez-Balibrea E
World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
[TBL] [Abstract][Full Text] [Related]
15. Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment.
Mukaida N; Sasaki S; Baba T
Mediators Inflamm; 2014; 2014():170381. PubMed ID: 24966464
[TBL] [Abstract][Full Text] [Related]
16. A CXCL1 paracrine network links cancer chemoresistance and metastasis.
Acharyya S; Oskarsson T; Vanharanta S; Malladi S; Kim J; Morris PG; Manova-Todorova K; Leversha M; Hogg N; Seshan VE; Norton L; Brogi E; Massagué J
Cell; 2012 Jul; 150(1):165-78. PubMed ID: 22770218
[TBL] [Abstract][Full Text] [Related]
17. Functions of the CXC ligand family in the pancreatic tumor microenvironment.
Lee NH; Nikfarjam M; He H
Pancreatology; 2018 Oct; 18(7):705-716. PubMed ID: 30078614
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of CXC chemokines and their receptors in cancer.
Vinader V; Afarinkia K
Future Med Chem; 2012 May; 4(7):853-67. PubMed ID: 22571611
[TBL] [Abstract][Full Text] [Related]
19. The Role of CXC Chemokine Receptors 1-4 on Immune Cells in the Tumor Microenvironment.
Susek KH; Karvouni M; Alici E; Lundqvist A
Front Immunol; 2018; 9():2159. PubMed ID: 30319622
[TBL] [Abstract][Full Text] [Related]
20. Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor.
Li BH; Garstka MA; Li ZF
Mol Immunol; 2020 Jan; 117():201-215. PubMed ID: 31835202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
